Claritas receives New York State Clinical Laboratory Permit

Approval received for Pediatric Neurology Region of Interest and Claritas Clinical Exome

January 05, 2017

On January 4, 2017, Claritas Genomics received the New York State Clinical Laboratory Permit with specific approval for the Claritas Clinical Exome and the Pediatric Neurology Region of Interest. Read the Press Release here

About Claritas

Claritas Genomics serves children affected with complex genetic disorders by providing timely and accurate results, resolving families’ long search for answers. By combining clinical expertise of the world’s best pediatric specialists with innovative platform solutions, Claritas is working to improve patient care and enable new discoveries. We are committed to the highest quality and accessibility of information and our interpretive services and unique approach to reporting set the standard for reliably and clearly communicating genetic information.

Now is the time to integrate genomics into clinical practice to inform, guide and improve medical treatment for kids around the world.